Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > NO Institutional support
View:
Post by txbioinv on Mar 27, 2015 2:42pm

NO Institutional support

With little or no institutional support combined with TST huge share float; its just too easy to keep the sp suppressed by the MM's/brokers/etc. As painful as it sounds, a RS and immediate uplisting might be the way to go. LBIO did it recently and I believe ADXS went thru it; neither has an approved drug yet but are close. Either we need shares placed in the right hands with the right intentions OR we need a severely reduced share count. The other last thing to get this sp moving north is some concrete positive developments with the FDA. GL longtimers
Comment by DamnYankees on Mar 27, 2015 6:22pm
Correct TXB, but on the upside Pharma are paying incredible premiums for late stage pipeline products. Every week there is a new precedent being set for projected revenue.  These valuations are at historical highs, by a freaking mile. Whatever TST may be giving up in SP management they should be receiving back 5 fold in speculation of a partnership or buyout alone. Multiple partners have been ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities